DNAnexus, Inc.

The Precision Health Data Cloud

[DNAnexus, Inc. @dnanexus]

By unifying the multimodal data in our Trusted Research Environment (TRE), the team identified 102 genes causally driving overall survival using our Omics Data Agent and Aitia’s REFS platform to build a clinico-genomic cohort and perform causal AI analysis.

[DNAnexus, Inc. @dnanexus]

“No single layer tells the complete story. But when you bring them together…patterns emerge that you simply cannot see any other way.” https://t.co/PmbGsNAxze

#AIInnovation #PharmaTech #Pharma #PrecisionMedicine #DigitalHealth #Genomics #DrugDiscovery #Oncology

[DNAnexus, Inc. @dnanexus]

The article walks through our collaborative study with a partner AMC to solve a breast cancer survival paradox; why do patients with invasive lobular carcinoma (ILC) show a 15% overall survival advantage over patients with the more common invasive ductal carcinoma (IDC)?

[DNAnexus, Inc. @dnanexus]

@John_E_Dominy thank you so much for sharing, I'll pass that along to the team!

[DNAnexus, Inc. @dnanexus]

A diverse population health resource is powering new insights into human health. https://t.co/rkT4h1ZPhI

#PrecisionMedicine #PopulationHealth #Biobanks #PakistanGenomeResource #DiversePopulations #DrugDiscovery #Genomics #GeneticVariants

[DNAnexus, Inc. @dnanexus]

He highlighted that the best sponsors are tackling modality complexity by building curated partner ecosystems. He doesn’t see generalists going away; they’re still valued for programs that are focused on operational scale and coordination.

[DNAnexus, Inc. @dnanexus]

“The shift is real…What's driving it is modality complexity outpacing what any single partner can credibly cover.” https://t.co/IVe5CVudys

#PharmaTech #Pharma #DrugDevelopment #PrecisionMedicine #PharmaRD #Multimodal

[DNAnexus, Inc. @dnanexus]

Todd Oakland spoke to Pharma's Almanac about the movement away from one-stop-shop outsourcing toward deeper modality-specific expertise.

[DNAnexus, Inc. @dnanexus]

Creating a resource for the Pakistani population aids in the discovery of rare genetic variants and biomarkers. DNAnexus is honored to be the precision health platform powering this team’s analyses, paving the way to make precision medicine a reality for all.

[DNAnexus, Inc. @dnanexus]

US and Pakistani researchers have created the Pakistan Genome Resource (PGR), a biobank comprising 173,303 participants. Members from pharma & health centers worked together to tackle one of the toughest challenges in precision health; studying under-represented populations.

[DNAnexus, Inc. @dnanexus]

See our new AI-powered innovations next week at #BIO2026! We’re excited to connect with the public health community and demonstrate how our solutions are enabling the future of precision health. https://t.co/QaGPnP7l5i

#AIinHealthcare #AIInnovation #PrecisionMedicine

[DNAnexus, Inc. @dnanexus]

We're heading to HLTH Europe next week to showcase our new solutions powering the AI transformation in precision health. Meet with us to see how our new product innovations provide faster insight, stronger governance, and supercharge user productivity. https://t.co/e8BVzErucN

[DNAnexus, Inc. @dnanexus]

Jimita Parekh, VP of Regulatory Technology Innovation, will be speaking on June 15: “ICH M11 in Action: Digital Protocols, AI, and Cloud for Patient-Centered Regulatory Science.” Hear how ICH M11, AI, & digital transformation are reshaping regulatory science to benefit patients.

[DNAnexus, Inc. @dnanexus]

Join us next week at #DIA2026! Meet with us to see how we’re advancing #regulatory science with our cloud-based solutions built for life sciences: https://t.co/Qrupqzdhun

#AIInnovation #RegulatoryInnovation #RegulatoryReliance

[DNAnexus, Inc. @dnanexus]

We’re excited to connect with leaders next week at the Multi-Omics Technology Trade Gateway Event. Schedule time to connect with us to learn how our platform turns multiomics data into an evidence engine for AI-driven scientific breakthroughs: https://t.co/egXRJqtB77

[DNAnexus, Inc. @dnanexus]

Aritro Nath & Nipun Kakkar will discuss the latest technological approaches being translated into clinical practice, including their application in clinical trials to support real-world decision making.

[DNAnexus, Inc. @dnanexus]

Next Tuesday: see how the convergence of AI and multimodal real-world data is transforming precision oncology: https://t.co/TajyrFwuue

#Oncology #CityofHope #AI #ClinicalTrials #PrecisionMedicine #CancerResearch

[DNAnexus, Inc. @dnanexus]

We’re excited to meet with other industry leaders at #FOGBoston! Our latest innovations are empowering organizations to leverage complex multimodal data and AI-driven workflows. Meet with us to see how we can power your scientific discovery. https://t.co/ocjYj1Mdxb

[DNAnexus, Inc. @dnanexus]

Join us this week at #ASCO26 to learn how our solutions provide an evidence engine for AI-driven oncology breakthroughs!

Setup time to meet with us and see how our recently announced solutions are powering the next era of precision health: https://t.co/uMwKlLc1tY

[DNAnexus, Inc. @dnanexus]

Learn how we’re powering the future of pharma at next week’s Digi-Tech Pharma & AI conference. Schedule time with us to see how our latest innovations operationalizing AI across critical scientific workflows with full regulatory readiness. https://t.co/0KWr2CGIJi
@corvusglobal